Muhlenkamp & Co. Inc. Acquires Shares of 129,569 Bristol-Myers Squibb (NYSE:BMY) : vimarsana.com

Muhlenkamp & Co. Inc. purchased a new stake in Bristol-Myers Squibb (NYSE:BMY – Free Report) during the second quarter, HoldingsChannel.com reports. The firm purchased 129,569 shares of the biopharmaceutical company’s stock, valued at approximately $8,286,000. Bristol-Myers Squibb accounts for 2.9% of Muhlenkamp & Co. Inc.’s holdings, making the stock its 17th largest holding. Other hedge […]

Related Keywords

Philadelphia , Pennsylvania , United States , Bristol Myers Squibb , Pomalyst Imnovid , Robertm Plenge , Ann Powell , Morgan Stanley , Cigna Investments Inc , Bristol Myers Squibb Company , Catalyst Financial Partners , Keystone Wealth Services , Credit Suisse Group , Dillon Associates Inc , Abbrea Capital , Muhlenkamp Co , Free Report , Myers Squibb , Financial Partners , Wealth Services , Suisse Group , Capital Markets , Get Free Report , Myers Squibb Company , Visit Holdingschannel , Bristol Myers Squibb Daily , Nyse Bmy , Bmy , Medical , 11012210 , Sec Filings , 13f , Hedge Fund Holdings , Institutional Investor Holdings ,